Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy

The RAS/RAF/MEK/ERK (MAPK) signaling cascade is essential for cell inter- and intra-cellular communication, which regulates fundamental cell functions such as growth, survival, and differentiation. The MAPK pathway also integrates signals from complex intracellular networks in performing cellular fu...

Full description

Bibliographic Details
Published in:	Cells
Main Authors:	Ufuk Degirmenci, Mei Wang, Jiancheng Hu
Format:	Article
Language:	English
Published:	MDPI AG 2020-01-01
Subjects:	ras gtpases raf family kinases ras/raf/mek/erk signaling braf(v600e) raf inhibitors paradoxical activation protein–protein interactions synthetic lethal neoplasm
Online Access:	https://www.mdpi.com/2073-4409/9/1/198

Similar Items

Oxymatrine Inhibits Proliferation and Migration of Vulvar Squamous Cell Carcinoma Cells via Attenuation of the RAS/RAF/MEK/ERK Pathway
by: Wang Y, et al.
Published: (2020-03-01)

Bufalin inhibits hepatocellular carcinoma progression by blocking EGFR-mediated RAS-RAF-MEK-ERK pathway activation
by: Jingwen Liu, et al.
Published: (2025-08-01)

Targeting RAS–RAF–MEK–ERK signaling pathway in human cancer: Current status in clinical trials
by: Yanlin Song, et al.
Published: (2023-01-01)

CircRAPGEF5 acts as a modulator of RAS/RAF/MEK/ERK signaling during colorectal carcinogenesis
by: Zhipeng Yin, et al.
Published: (2024-08-01)

Investigation of Molecular Changes in RAS/RAF/MEK/MAPK Pathway in Serous Adenocarcinomas and Serous Borderline Tumors of Ovary
by: Cevriye Cansız Ersöz
Published: (2020-08-01)

Geniposide alleviates lipopolysaccharide-caused apoptosis of murine kidney podocytes by activating Ras/Raf/MEK/ERK-mediated cell autophagy
by: Xia Li, et al.
Published: (2019-12-01)

A diaryl urea derivative, SMCl inhibits cell proliferation through the RAS/RAF/MEK/ERK pathway in hepatocellular carcinoma
by: Yue Fu, et al.
Published: (2025-07-01)

Dayuan Yin alleviates symptoms of HCoV-229E-induced pneumonia and modulates the Ras/Raf1/MEK/ERK pathway
by: Rui Li, et al.
Published: (2024-11-01)

The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy
by: Jimin Yuan, et al.
Published: (2020-08-01)

Crystal Structure Reveals the Full Ras–Raf Interface and Advances Mechanistic Understanding of Raf Activation
by: Trinity Cookis, et al.
Published: (2021-07-01)

An oncogenic mutant of RHEB, RHEB Y35N, exhibits an altered interaction with BRAF resulting in cancer transformation
by: Jeffrey J. Heard, et al.
Published: (2018-01-01)

RETRACTED ARTICLE: Syndecan-1 suppresses cell growth and migration via blocking JAK1/STAT3 and Ras/Raf/MEK/ERK pathways in human colorectal carcinoma cells
by: Shaojun Wang, et al.
Published: (2019-11-01)

Huanglian Jiedu decoction alleviates neurobehavioral damage in mice with chronic alcohol exposure through the RAS-RAF-MEK-ERK pathway
by: Yun Chen, et al.
Published: (2024-04-01)

Global gene analysis identifying genes commonly regulated by the Ras/Raf/MEK and type I IFN pathways
by: Y. Komatsu, et al.
Published: (2015-06-01)

ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cells
by: Giulia Cesi, et al.
Published: (2017-06-01)

Targeting RAF dimers in RAS mutant tumors: From biology to clinic
by: Huanhuan Yin, et al.
Published: (2024-05-01)

Rat Sarcoma Virus Family Genes in Acute Myeloid Leukemia: Pathogenetic and Clinical Implications
by: Shaimaa Khattab, et al.
Published: (2025-01-01)

Novel RAF‐directed approaches to overcome current clinical limits and block the RAS/RAF node
by: Rossella Scardaci, et al.
Published: (2024-06-01)

Unveiling the domain-specific and RAS isoform-specific details of BRAF kinase regulation
by: Tarah Elizabeth Trebino, et al.
Published: (2023-12-01)

Recent Developments in Targeting RAS Downstream Effectors for RAS-Driven Cancer Therapy
by: Ozge Tatli, et al.
Published: (2021-12-01)

Design, Synthesis, and Anti-Leukemic Evaluation of a Series of Dianilinopyrimidines by Regulating the Ras/Raf/MEK/ERK and STAT3/c-Myc Pathways
by: Chaoyan Wang, et al.
Published: (2024-04-01)

Mechanism of Inhibition of Inflammation in Osteoarthritis by Tougu Xiaotong Capsule via Regulating Ras-Raf-MEK1/2-ERK1/2 Signaling Pathway
by: Munan LIN, et al.
Published: (2021-06-01)

Allosteric Kinase Inhibitors Reshape MEK1 Kinase Activity Conformations in Cells and In Silico
by: Jakob Fleischmann, et al.
Published: (2021-03-01)

Cellular model of neuronal atrophy induced by DYNC1I1 deficiency reveals protective roles of RAS-RAF-MEK signaling
by: Zhi-Dong Liu, et al.
Published: (2016-08-01)

Mechanisms of Ras Membrane Organization and Signaling: Ras Rocks Again
by: Daniel Abankwa, et al.
Published: (2020-11-01)

ERK: A Double-Edged Sword in Cancer. ERK-Dependent Apoptosis as a Potential Therapeutic Strategy for Cancer
by: Reiko Sugiura, et al.
Published: (2021-09-01)

Remote Continuous Microinjury-Triggered Cytokines Facilitate Severe Diabetic Foot Ulcer Healing via the Ras/Raf/MEK/ERK Pathway
by: Huang X, et al.
Published: (2025-02-01)

Molecular-genetic mechanisms of the signal cascade RAS-RAF-MEK-ERK associated with the development of the tumor process and the purpose of targeted drugs for colorectal cancer
by: A. N. Toropovsky, et al.
Published: (2021-08-01)

Renal sympathetic denervation attenuates left ventricle hypertrophy in spontaneously hypertensive rats by suppressing the Raf/MEK/ERK signaling pathway
by: Bing Xiao, et al.
Published: (2021-02-01)

Efficiency of B-RAF-/MEK-inhibitors in B-RAF mutated Ameloblastoma: Case report and review of literature
by: Reinhard Büttner, et al.
Published: (2023-12-01)

Preclinical characterization of tunlametinib, a novel, potent, and selective MEK inhibitor
by: Yahong Liu, et al.
Published: (2023-09-01)

Deciphering the pathogenic role of rare RAF1 heterozygous missense mutation in the late-presenting DDH
by: Yuzhao Liu, et al.
Published: (2024-06-01)

TCF19 promotes cell proliferation and tumor formation in lung cancer by activating the Raf/MEK/ERK signaling pathway
by: Yahui Tian, et al.
Published: (2024-07-01)

Envoplakin Inhibits Macrophage Polarization by Altering the Inflammatory Tumor Microenvironment of Melanoma Through the RAS / ERK Signaling Pathway
by: Cai W, et al.
Published: (2024-03-01)

RNF173 suppresses RAF/MEK/ERK signaling to regulate invasion and metastasis via GRB2 ubiquitination in Hepatocellular Carcinoma
by: Jie Zhou, et al.
Published: (2023-08-01)

Anticancer activity of sugiol against ovarian cancer cell line SKOV3 involves mitochondrial apoptosis, cell cycle arrest and blocking of the RAF/MEK/ERK signalling pathway
by: Yan Wang, et al.
Published: (2017-11-01)

Selective inhibition of BRAF and CRAF sensitizes NF1-deficient malignant peripheral nerve sheath tumors to MEK inhibitors
by: Jiawan Wang, et al.
Published: (2025-09-01)

Does Ras Activate Raf and PI3K Allosterically?
by: Ruth Nussinov, et al.
Published: (2019-11-01)

BRAF(V600E) mutation together with loss of Trp53 or pTEN drives the origination of hairy cell leukemia from B-lymphocytes
by: Jiajun Yap, et al.
Published: (2023-08-01)

Influenza A virus replication has a stronger dependency on Raf/MEK/ERK signaling pathway activity than SARS-CoV-2
by: Helen Hoffmann, et al.
Published: (2023-10-01)